ColdRif Cough Syrup Controversy: How States Responded to Safety Concerns
A Medicine Under Scrutiny Concerns surrounding ColdRif cough syrup led to regulatory action in several Indian states in 2025 after reports connected the medicine with the deaths of children in Madhya Pradesh and Rajasthan. State-Level Action Authorities began examining reports of children becoming seriously ill after consuming the syrup. Subsequent testing raised concerns about possible
ColdRif Cough Syrup Controversy: How States Responded to Safety Concerns Read More »


